Abstract

The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 2

Author(s): Williams LaVonn A

Issue: Jan/Feb 2019 - Volume 23, Number 1

Page(s): 14-21

Download in electronic PDF format for $75
  • The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 2 Page 1
  • The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 2 Page 2
  • The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 2 Page 3
  • The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 2 Page 4
  • The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 2 Page 5
  • The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 2 Page 6
  • The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 2 Page 7
  • The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 2 Page 8

Abstract

Gout, a common and complex form of inflammatory arthritis, is characterized by abnormally elevated levels of uric acid in the blood. The most current estimate from the Centers for Disease Control and Prevention shows an increase from 52.5 million to 54.4 million people in the U.S. have arthritis or one of the rheumatic diseases. There are over 100 rheumatic diseases and conditions. In the U.S., the most common types of arthritis or rheumatic diseases are osteoarthritis, gout, fibromyalgia, and rheumatoid arthritis, in that order according to prevalence. This article focuses on gout. Gout can be effectively treated and managed with a combination of medication (manufactured and/or compounded) and self-management strategies. Part 1 of this 2-part article provided the definition of gout and a brief history of gout. Part 2 continues the discussion of gout and includes examples of compounded formulations used in the treatment of gout.

Related Keywords

  • gout
  • joint disease
  • inflammatory arthritis
  • uric acid levels
  • hyperuricemia
  • monosodium urate, monohydrate crystal deposits
  • MSU crystals
  • tophi
  • uric acid testing
  • purine metabolism
  • synovial fluid
  • formulations
  • allopurinol
  • indomethacin
  • chronic kidney disease
  • renal disorders
  • prednisone
  • nonsteroidal anti-inflammatory drugs
  • NSAIDS

Related Categories

  • FORMULATIONS
  • PAIN MANAGEMENT
  • ALLERGY/IMMUNOLOGY/INFLAMMATION
  • MUSCULOSKELETAL DISORDERS
  • PREVENTIVE MEDICINE/WELLNESS
  • UROLOGY/URINARY TRACT

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jan/Feb 2019
Pg. 14-21
The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 2
Author(s): Williams LaVonn A
Jul/Aug 2018
Pg. 284-287
The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 1
Author(s): Williams LaVonn
Jul/Aug 2003
Pg. 288-291
Basics of Compounding for Raynaud's Disease
Author(s): Glasnapp Andrew
Jul/Aug 2003
Pg. 266-270
Sensitization Therapy for Warts
Author(s): Kuntz Rachael
Jul/Aug 1999
Pg. 309-310
Acidifying Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
May/Jun 2003
Pg. 188-191
Treating Canine Hepatic Disease
Author(s): Davidson Gigi S
Sep/Oct 2015
Pg. 410
Trichloroacetic Acid 20%, Salicylic Acid 20%, Lactic Acid 10% in Flexible Collodion
Author(s): Allen Loyd V Jr
Jan/Feb 2013
Pg. 74-85
View Sample
The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women
Author(s): Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K
Nov/Dec 2003
Pg. 426-435
View Sample
Sore Nipples in Breastfeeding Mothers: Causes and Treatments
Author(s): Albright Lisa M
Jul/Aug 2008
Pg. 295-304
Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women
Author(s): Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K, Pinson Barbara, Price Carol
Jul/Aug 2022
Pg. 293-296
Compounding for Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases
Author(s): Harrington Amy, Williams LaVonn
Mar/Apr 2004
Pg. 126-129
Basics of Compounding for the Treatment of Warts
Author(s): Allen Loyd V Jr
May/Jun 2023
Pg. 182-190
Warts: Pathophysiology, Types, Treatments, and Pharmaceutical Compounds
Author(s): Touprong Robin, Thompson Tara, Williams LaVonn A
Jan/Feb 2000
Pg. 72-75
Physicochemical Stability of Compounded Creams Containing alpha-Hydroxy Acids
Author(s): de Villiers Melgardt M, Narsai Kirti, van der Watt Jakkie G
Mar/Apr 1997
Pg. 132-134
Stability of Aminocaproic Acid Injection Admixtures in 5% Dextrose Injection and 0.9% Sodium Chloride Injection
Author(s): Zhang Yan-ping, Trissel Lawrence A
Sep/Oct 2007
Pg. 404-410
Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 3: Risk Levels
Author(s): Allen Loyd V Jr, Okeke Claudia C
Nov/Dec 2022
Pg. 446-466
Compounding with Biotechnology Products, Part 2: Product-specific Considerations
Author(s): Allen Loyd V Jr
Jul/Aug 2013
Pg. 328
Allopurinol Sodium 4-mg/mL Injection
Author(s): Allen Loyd V Jr
May/Jun 2025
Pg. 208
Trichloroacetic Acid 20%, Salicylic Acid 20%, Lactic Acid 10% in Flexible Collodion
Author(s):
Mar/Apr 2012
Pg. 125-132
A Concise Discussion of Headache Types, Part 1
Author(s): Williams LaVonn A